Business

JLHL: Revenue up 17.5%, EBITDA up 22.5%, and major expansion projects progressing on schedule

JLHL: Revenue up 17.5%, EBITDA up 22.5%, and major expansion projects progressing on schedule

Jupiter Life Line Hospitals Ltd.May 12, 20255
JLHL: Revenue up 17.5%, EBITDA up 22.5%, and major expansion projects progressing on schedule

About this update from Jupiter Life Line Hospitals Ltd.

Revenue grew 17.5% to ₹1,261.5 crore with EBITDA up 22.5% and PAT up 9.6%. Bed capacity expanded to 1,061, and major greenfield and brownfield projects are on track. Strong liquidity, robust ESG initiatives, and all hospitals received NABH Digital Health Gold Standard accreditation.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Jupiter Life Line Hospitals Ltd.